Laura Herrera-Hidalgo

Has grant

University Name
Country flag
Spain

Research Interests

Explore related searches

Contact this professor

LinkedIn
ORCID
Google Scholar

Recent Grants

Grant: Close

ADN proviral y ARN del VIH asociado a monocitos como causa de la activación inmune persistente en pacientes infectados por el VIH y virológicamente suprimidos su papel en pacientes inmune discordante

Open Date: 2021-01-01

Close Date: 2023-01-01

Grant: Close

Rio Hortega

Open Date: 2020-01-01

Close Date: 2022-01-01

Grant: Close

Estudio de estabilidad de antimicrobianos en condiciones análogas a las utilizadas en los programas de tratamiento antibiótico domiciliario endovenoso (TADE)

Open Date: 2020-01-01

Close Date: 2021-01-01

Grant: Close

Ensayo clínico fase 4, aleatorizado, para evaluar el efecto en la recuperación inmunológica y en la reducción del reservorio viral y de la activación inmune de una terapia antirretroviral triple basada en dolutegravir más tenofovir alafenamida /emtricitabina versus una biterapia con dolutegravir más lamivudina en pacientes con infección por el VIH sin tratamiento previo.

Open Date: 2020-01-01

Close Date: 2022-01-01

Grant: Close

Impacto clínico y microbiológico de un programa de optimización de antimicrobianos específico para centros socio-sanitarios. Ensayo clínico aleatorizado por grupos. Ensayo PROA-SENIOR

Open Date: 2018-01-01

Close Date: 2021-01-01

Articles (10)

Model-Informed Precision Dosing Software Tools for Dosage Regimen Individualization: A Scoping Review

Background: Pharmacokinetic nomograms, equations, and software are considered the main tools available for Therapeutic Drug Monitoring (TDM). Model-informed precision dosing (MIPD) is an advanced discipline of TDM that allows dose individualization, and requires a software for knowledge integration and statistical calculations. Due to its precision and extensive applicability, the use of these software is widespread in clinical practice. However, the currently available evidence on these tools remains scarce. Objectives: To review and summarize the available evidence on MIPD software tools to facilitate its identification, evaluation, and selection by users. Methods: An electronic literature search was conducted in MEDLINE, EMBASE, OpenAIRE, and BASE before July 2022. The PRISMA-ScR was applied. The main inclusion criteria were studies focused on developing software for use in clinical practice, research, or modelling. Results: Twenty-eight software were classified as MIPD software. Ten are currently unavailable. The remaining 18 software were described in depth. It is noteworthy that all MIPD software used Bayesian statistical methods to estimate drug exposure and all provided a population model by default, except NONMEN. Conclusions: Pharmacokinetic software have become relevant tools for TDM. MIPD software have been compared, facilitating its selection for use in clinical practice. However, it would be interesting to standardize the quality and validate the software tools.

Year:

2023

Collaborators (3)

Jesús Rodríguez-Baño

Professor

Universidad de Sevilla

SPAIN

Marta Alonso Moreno

Bellvitge University Hospital

SPAIN

Luis Fernando Lopez.Cortes

Head of research group

Instituto de Biomedicina de Sevilla

SPAIN
Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI